Characterization of Biological Processes Through Automated Image Analysis Read more about Characterization of Biological Processes Through Automated Image Analysis
Dark Pixel Intensity Determination and Its Applications in Normalizing Different Exposure Time and Autofluorescence Removal Read more about Dark Pixel Intensity Determination and Its Applications in Normalizing Different Exposure Time and Autofluorescence Removal
Highly multiplexed single-cell analysis of formalinfixed, paraffin-embedded cancer tissue Read more about Highly multiplexed single-cell analysis of formalinfixed, paraffin-embedded cancer tissue
A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma. Read more about A single slide multiplex assay for the evaluation of classical Hodgkin lymphoma.
Expression of PD-L1 in colorectal cancer that lack mutations in RAS or TP53 genes Read more about Expression of PD-L1 in colorectal cancer that lack mutations in RAS or TP53 genes
BRAF mutation and PD-L1 expression in melanoma: Comparison between multiple PD-L1 IHC clones and BRAF mutation evaluated by FDA-approved kits versus NGS Read more about BRAF mutation and PD-L1 expression in melanoma: Comparison between multiple PD-L1 IHC clones and BRAF mutation evaluated by FDA-approved kits versus NGS
Using Targeted Enrichment RNA Sequencing in the Diagnosis of Hematologic Neoplasms in Fresh and Paraffin-Embedded Tissue Read more about Using Targeted Enrichment RNA Sequencing in the Diagnosis of Hematologic Neoplasms in Fresh and Paraffin-Embedded Tissue
Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms Read more about Potential Familial Predisposition to Hematologic Neoplasm Detected Incidentally in Adult Patients Presenting with Myeloid Neoplasms
MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing Read more about MDS Diagnosis Using cfRNA Profiling By Targeted Enrichment Next Generation Sequencing
IDH1 and IDH2: founding or progressor mutations in myeloid neoplasms Read more about IDH1 and IDH2: founding or progressor mutations in myeloid neoplasms